2017
DOI: 10.1002/cbin.10912
|View full text |Cite
|
Sign up to set email alerts
|

PKG II effectively reversed EGF‐induced protein expression alterations in human gastric cancer cell lines

Abstract: Epidermal growth factor receptor (EGFR) plays an important role in gastric cancer (GC) progression. Our previous data demonstrated that type II cGMP-dependent protein kinase (PKG II) could block the EGF-EGFR axis as well as down-stream signaling pathways, for example, MAPK, PI3 K, and PLC in GC cells. However, the exact mechanisms of PKG II against cancer remain unclear. Therefore, the present work was to address the above question. Human GC cell line AGS was infected with adenoviral construct encoding cDNA of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 38 publications
(46 reference statements)
0
2
0
Order By: Relevance
“…HMG 20 (Potri.005G246700, Potri.011G168800) was reported to have a potential role for β-dystrobrevin in neuronal differentiation, and histone deacetylase activity regulation [ 33 , 34 ]. PKGII (Potri.018G084900) inhibited the proliferation of various cancer cell lines in humans [ 35 , 36 , 37 ]. MORPHEUS (Potri.013G006000) MORPHEUS (Potri.013G006000) was a plant-specific epigenetic regulator of transcriptional gene silencing and affected cytosine methylation status [ 38 ].…”
Section: Resultsmentioning
confidence: 99%
“…HMG 20 (Potri.005G246700, Potri.011G168800) was reported to have a potential role for β-dystrobrevin in neuronal differentiation, and histone deacetylase activity regulation [ 33 , 34 ]. PKGII (Potri.018G084900) inhibited the proliferation of various cancer cell lines in humans [ 35 , 36 , 37 ]. MORPHEUS (Potri.013G006000) MORPHEUS (Potri.013G006000) was a plant-specific epigenetic regulator of transcriptional gene silencing and affected cytosine methylation status [ 38 ].…”
Section: Resultsmentioning
confidence: 99%
“…Among the other top-performing drugs, the sensitivity of Gefitinib, an EGFR inhibitor has been attributed to the expression of ARHGAP8, a gene implicated in EGFR-mediated ERK1/2 phosphorylation and oncogenesis [51][52][53] . The expression of other bimodal genes associated with lapatinib sensitivity such as MARVELD3 and EPN3 has been reported to promote migration and invasion of cancer cells [54][55][56] .…”
Section: Validation Of Predictorsmentioning
confidence: 99%